Page 35 - Preventive Screening News Today

Researchers derived and validated a proprietary screening test to detect pancreatic cancer in people with new-onset diabetes. The test uses an epigenetic analysis of a 20 mL blood specimen.

This study, published on researchsquare.com as a preprint and not yet peer reviewed, found no meaningful loss of sensitivity with MRI compared with CT, and eliminates radiation exposure.

The American Gastroenterology Association expects this guidance will eliminate surprise bills and give patients peace of mind regarding coverage.

The findings suggest that "multistage screening and appropriate access to diagnostic services can really move the needle on the early detection of autism and reducing disparities in autism diagnosis and detection."

Despite major loss to follow-up, a Mexican study confirms the importance of HPV testing for early detection of high-grade cervical lesions compared to cytology alone.

Emergency departments will work round-the-clock on all days

Increases in BP among US adults during the COVID-19 pandemic could signal a looming increase in future cardiovascular disease mortality, researchers warn.

A new blood test that identifies a variant of the protein P53 appears to predict Alzheimers disease progression up to 6 years in advance of a clinical diagnosis, early research suggests.

The findings are based on a study conducted in Australia, which assessed melanoma-specific and all-cause mortality associated with melanoma identified through routine skin checks.

Dr Daniel Kopans has been an outspoken critic of the ongoing federally funded trial that is comparing 3-D to 2-D mammography. Now his criticisms are gathered in a journal essay.